Parkinson's disease: From genetics to clinical practice

Current Genomics

Volumn 14, Issue 8, 2013, Pages 560-567

  Clarimón, Jordi ^a,b   Kulisevsky, Jaime ^a,b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

Author keywords

Clinical genetics; Genetic risk factor; Genetic testing; Genetics; Mendelian genes; PARK; Parkinson's disease

Indexed keywords

ALPHA SYNUCLEIN;

CHROMOSOME 16; CHROMOSOME 21; CHROMOSOME 22; CLINICAL PRACTICE; COGNITION; DEMENTIA; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC COUNSELING; GENETIC POLYMORPHISM; GENETIC SCREENING; GENETICS; HAPLOTYPE; HUMAN; META ANALYSIS (TOPIC); MISSENSE MUTATION; NONSENSE MUTATION; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; REVIEW; RISK FACTOR; SEQUENCE ANALYSIS;

EID: 84894086893     PISSN: 13892029     EISSN: 18755488     Source Type: Journal    
DOI: 10.2174/1389202914666131210212305     Document Type: Review

References (79)

1. Polymeropoulos, M.H.; Hurko, O.; Hsu, F.; Rubenstein, J.; Basnet, S.; Lane, K.; Dietz, H.; Spetzler, R.F.; Rigamonti, D. Linkage of the locus for cerebral cavernous hemangiomas to human chromosome 7q in four families of Mexican-American descent. Neurology, 1997, 48(3), 752-757.
2. Kruger, R.; Kuhn, W.; Muller, T.; Woitalla, D.; Graeber, M.; Kosel, S.; Przuntek, H.; Epplen, J.T.; Schols, L.; Riess, O. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat. Genet., 1998, 18(2), 106-108.
3. Zarranz, J.J.; Alegre, J.; Gomez-Esteban, J.C.; Lezcano, E.; Ros, R.; Ampuero, I.; Vidal, L.; Hoenicka, J.; Rodriguez, O.; Atares, B.; Llorens, V.; Gomez Tortosa, E.; del Ser, T.; Munoz, D.G.; de Yebenes, J.G. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann. Neurol., 2004, 55(2), 164-173.
4. Chartier-Harlin, M.C.; Kachergus, J.; Roumier, C.; Mouroux, V.; Douay, X.; Lincoln, S.; Levecque, C.; Larvor, L.; Andrieux, J.; Hulihan, M.; Waucquier, N.; Defebvre, L.; Amouyel, P.; Farrer, M.; Destee, A. Alpha-synuclein locus duplication as a cause of familial Parkinson's disease. Lancet, 2004, 364(9440), 1167-1169.
5. Singleton, A.B.; Farrer, M.; Johnson, J.; Singleton, A.; Hague, S.; Kachergus, J.; Hulihan, M.; Peuralinna, T.; Dutra, A.; Nussbaum, R.; Lincoln, S.; Crawley, A.; Hanson, M.; Maraganore, D.; Adler, C.; Cookson, M.R.; Muenter, M.; Baptista, M.; Miller, D.; Blancato, J.; Hardy, J.;Gwinn-Hardy, K. alpha-Synuclein locus triplication causes Parkinson's disease. Science, 2003, 302(5646), 841.
6. Kann, M.; Jacobs, H.; Mohrmann, K.; Schumacher, K.; Hedrich, K.; Garrels, J.; Wiegers, K.; Schwinger, E.; Pramstaller, P.P.; Breakefield, X.O.; Ozelius, L.J.; Vieregge, P.; Klein, C. Role of parkin mutations in 111 community-based patients with early-onset parkinsonism. Ann. Neurol., 2002, 51(5), 621-625.
7. Mellick, G.D.; Siebert, G.A.; Funayama, M.; Buchanan, D.D.; Li, Y.; Imamichi, Y.; Yoshino, H.; Silburn, P.A.; Hattori, N. Screening PARK genes for mutations in early-onset Parkinson's disease patients from Queensland, Australia. Parkinsonism Relat. Disord., 2009, 15(2), 105-109.
8. Lucking, C.B.; Durr, A.; Bonifati, V.; Vaughan, J.; De Michele, G.; Gasser, T.; Harhangi, B.S.; Meco, G.; Denefle, P.; Wood, N.W.; Agid, Y.; Brice, A. Association between early-onset Parkinson's disease and mutations in the parkin gene. N. Engl. J. Med., 2000, 342(21), 1560-1567.
9. Gouider-Khouja, N.; Larnaout, A.; Amouri, R.; Sfar, S.; Belal, S.; Ben Hamida, C.; Ben Hamida, M.; Hattori, N.; Mizuno, Y.; Hentati, F. Autosomal recessive parkinsonism linked to parkin gene in a Tunisian family. Clinical, genetic and pathological study. Parkinsonism Relat. Disord., 2003, 9(5), 247-251.
10. Pramstaller, P.P.; Schlossmacher, M.G.; Jacques, T.S.; Scaravilli, F.; Eskelson, C.; Pepivani, I.; Hedrich, K.; Adel, S.; Gonzales-McNeal, M.; Hilker, R.; Kramer, P.L.; Klein, C. Lewy body Parkinson's disease in a large pedigree with 77 Parkin mutation carriers. Ann. Neurol., 2005, 58(3), 411-422.
11. Takahashi, H.; Ohama, E.; Suzuki, S.; Horikawa, Y.; Ishikawa, A.; Morita, T.; Tsuji, S.; Ikuta, F. Familial juvenile parkinsonism: clinical and pathologic study in a family. Neurology, 1994, 44(3 Pt 1), 437-441.
12. Farrer, M.; Chan, P.; Chen, R.; Tan, L.; Lincoln, S.; Hernandez, D.; Forno, L.; Gwinn-Hardy, K.; Petrucelli, L.; Hussey, J.; Singleton, A.; Tanner, C.; Hardy, J.; Langston, J.W. Lewy bodies and parkinsonism in families with parkin mutations. Ann. Neurol., 2001, 50(3), 293-300.
13. Sasaki, S.; Shirata, A.; Yamane, K.; Iwata, M. Parkin-positive autosomal recessive juvenile Parkinsonism with alpha-synucleinpositive inclusions. Neurology, 2004, 63(4), 678-682.
14. Mori, H.; Kondo, T.; Yokochi, M.; Matsumine, H.; Nakagawa-Hattori, Y.; Miyake, T.; Suda, K.; Mizuno, Y. Pathologic and biochemical studies of juvenile parkinsonism linked to chromosome 6q. Neurology, 1998, 51(3), 890-892.
15. Foroud, T.; Uniacke, S.K.; Liu, L.; Pankratz, N.; Rudolph, A.; Halter, C.; Shults, C.; Marder, K.; Conneally, P.M.; Nichols, W.C. Heterozygosity for a mutation in the parkin gene leads to later onset Parkinson disease. Neurology, 2003, 60(5), 796-801.
16. Hedrich, K.; Marder, K.; Harris, J.; Kann, M.; Lynch, T.; Meija-Santana, H.; Pramstaller, P.P.; Schwinger, E.; Bressman, S.B.; Fahn, S.; Klein, C. Evaluation of 50 probands with early-onset Parkinson's disease for Parkin mutations. Neurology, 2002, 58(8), 1239-1246.
17. Lohmann, E.; Periquet, M.; Bonifati, V.; Wood, N.W.; De Michele, G.; Bonnet, A.M.; Fraix, V.; Broussolle, E.; Horstink, M.W.; Vidailhet, M.; Verpillat, P.; Gasser, T.; Nicholl, D.; Teive, H.; Raskin, S.; Rascol, O.; Destee, A.; Ruberg, M.; Gasparini, F.; Meco, G.; Agid, Y.; Durr, A.; Brice, A. How much phenotypic variation can be attributed to parkin genotype? Ann. Neurol., 2003, 54(2), 176-185.
18. Lucking, C.B.; Chesneau, V.; Lohmann, E.; Verpillat, P.; Dulac, C.; Bonnet, A.M.; Gasparini, F.; Agid, Y.; Durr, A.; Brice, A. Coding polymorphisms in the parkin gene and susceptibility to Parkinson disease. Arch. Neurol., 2003, 60(9), 1253-1256.
19. Hilker, R.; Klein, C.; Ghaemi, M.; Kis, B.; Strotmann, T.; Ozelius, L.J.; Lenz, O.; Vieregge, P.; Herholz, K.; Heiss, W.D.; Pramstaller, P.P. Positron emission tomographic analysis of the nigrostriatal dopaminergic system in familial parkinsonism associated with mutations in the parkin gene. Ann. Neurol., 2001, 49(3), 367-376.
20. Khan, N.L.; Valente, E.M.; Bentivoglio, A.R.; Wood, N.W.; Albanese, A.; Brooks, D.J.; Piccini, P. Clinical and subclinical dopaminergic dysfunction in PARK6-linked parkinsonism: an 18F-dopa PET study. Ann. Neurol., 2002, 52(6), 849-853.
21. Kumazawa, R.; Tomiyama, H.; Li, Y.; Imamichi, Y.; Funayama, M.; Yoshino, H.; Yokochi, F.; Fukusako, T.; Takehisa, Y.; Kashihara, K.; Kondo, T.; Elibol, B.; Bostantjopoulou, S.; Toda, T.; Takahashi, H.; Yoshii, F.; Mizuno, Y.; Hattori, N. Mutation analysis of the PINK1 gene in 391 patients with Parkinson disease. Arch. Neurol., 2008, 65(6), 802-808.
22. Ishihara-Paul, L.; Hulihan, M.M.; Kachergus, J.; Upmanyu, R.; Warren, L.; Amouri, R.; Elango, R.; Prinjha, R.K.; Soto, A.; Kefi, M.; Zouari, M.; Sassi, S.B.; Yahmed, S.B.; El Euch-Fayeche, G.; Matthews, P.M.; Middleton, L.T.; Gibson, R.A.; Hentati, F.; Farrer, M.J. PINK1 mutations and parkinsonism. Neurology, 2008, 71(12), 896-902.
23. Bonifati, V.; Rohe, C.F.; Breedveld, G.J.; Fabrizio, E.; De Mari, M.; Tassorelli, C.; Tavella, A.; Marconi, R.; Nicholl, D.J.; Chien, H.F.; Fincati, E.; Abbruzzese, G.; Marini, P.; De Gaetano, A.; Horstink, M.W.; Maat-Kievit, J.A.; Sampaio, C.; Antonini, A.; Stocchi, F.; Montagna, P.; Toni, V.; Guidi, M.; Dalla Libera, A.; Tinazzi, M.; De Pandis, F.; Fabbrini, G.; Goldwurm, S.; de Klein, A.; Barbosa, E.; Lopiano, L.; Martignoni, E.; Lamberti, P.; Vanacore, N.; Meco, G.; Oostra, B.A. Early-onset parkinsonism associated with PINK1 mutations: frequency, genotypes, and phenotypes. Neurology, 2005, 65(1), 87-95.
24. Annesi, G.; Savettieri, G.; Pugliese, P.; D'Amelio, M.; Tarantino, P.; Ragonese, P.; La Bella, V.; Piccoli, T.; Civitelli, D.; Annesi, F.; Fierro, B.; Piccoli, F.; Arabia, G.; Caracciolo, M.; Ciro Candiano, I.C.; Quattrone, A. DJ-1 mutations and parkinsonism-dementiaamyotrophic lateral sclerosis complex. Ann. Neurol., 2005, 58(5), 803-807.
25. Paisan-Ruiz, C.; Jain, S.; Evans, E.W.; Gilks, W.P.; Simon, J.; van der Brug, M.; Lopez de Munain, A.; Aparicio, S.; Gil, A.M.; Khan, N.; Johnson, J.; Martinez, J.R.; Nicholl, D.; Carrera, I.M.; Pena, A.S.; de Silva, R.; Lees, A.; Marti-Masso, J.F.; Perez-Tur, J.; Wood, N.W.; Singleton, A.B. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron, 2004, 44(4), 595-600.
26. Zimprich, A.; Biskup, S.; Leitner, P.; Lichtner, P.; Farrer, M.; Lincoln, S.; Kachergus, J.; Hulihan, M.; Uitti, R.J.; Calne, D.B.; Stoessl, A.J.; Pfeiffer, R.F.; Patenge, N.; Carbajal, I.C.; Vieregge, P.; Asmus, F.; Muller-Myhsok, B.; Dickson, D.W.; Meitinger, T.; Strom, T.M.; Wszolek, Z.K.; Gasser, T. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron, 2004, 44(4), 601-607.
27. Rubio, J.P.; Topp, S.; Warren, L.; St Jean, P.L.; Wegmann, D.; Kessner, D.; Novembre, J.; Shen, J.; Fraser, D.; Aponte, J.; Nangle, K.; Cardon, L.R.; Ehm, M.G.; Chissoe, S.L.; Whittaker, J.C.; Nelson, M.R.; Mooser, V.E. Deep sequencing of the LRRK2 gene in 14,002 individuals reveals evidence of purifying selection and independent origin of the p. Arg1628Pro mutation in Europe. Hum. Mutat., 33(7), 1087-1098.
28. Healy, D.G.; Falchi, M.; O'Sullivan, S.S.; Bonifati, V.; Durr, A.; Bressman, S.; Brice, A.; Aasly, J.; Zabetian, C.P.; Goldwurm, S.; Ferreira, J.J.; Tolosa, E.; Kay, D.M.; Klein, C.; Williams, D.R.; Marras, C.; Lang, A.E.; Wszolek, Z.K.; Berciano, J.; Schapira, A.H.; Lynch, T.; Bhatia, K.P.; Gasser, T.; Lees, A.J.; Wood, N.W. Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study. Lancet Neurol., 2008, 7(7), 583-590.
29. al-Din, S.N.; Anderson, M.; Eeg-Olofsson, O.; Trontelj, J.V. Neuro-ophthalmic manifestations of the syndrome of ophthalmoplegia, ataxia and areflexia: a review. Acta Neurol. Scand., 1994, 89(3), 157-163.
30. Hampshire, D.J.; Roberts, E.; Crow, Y.; Bond, J.; Mubaidin, A.; Wriekat, A.L.; Al-Din, A.; Woods, C.G. Kufor-Rakeb syndrome, pallido-pyramidal degeneration with supranuclear upgaze paresis and dementia, maps to 1p36. J. Med. Genet., 2001, 38(10), 680-682.
31. Ramirez, A.; Heimbach, A.; Grundemann, J.; Stiller, B.; Hampshire, D.; Cid, L.P.; Goebel, I.; Mubaidin, A.F.; Wriekat, A.L.; Roeper, J.; Al-Din, A.; Hillmer, A.M.; Karsak, M.; Liss, B.; Woods, C.G.; Behrens, M.I.; Kubisch, C. Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nat. Genet., 2006, 38(10), 1184-1191.
32. Morgan, N.V.; Westaway, S.K.; Morton, J.E.; Gregory, A.; Gissen, P.; Sonek, S.; Cangul, H.; Coryell, J.; Canham, N.; Nardocci, N.; Zorzi, G.; Pasha, S.; Rodriguez, D.; Desguerre, I.; Mubaidin, A.; Bertini, E.; Trembath, R.C.; Simonati, A.; Schanen, C.; Johnson, C.A.; Levinson, B.; Woods, C.G.; Wilmot, B.; Kramer, P.; Gitschier, J.; Maher, E.R.; Hayflick, S.J. PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron. Nat. Genet., 2006, 38(7), 752-754.
33. Kurian, M.A.; Morgan, N.V.; MacPherson, L.; Foster, K.; Peake, D.; Gupta, R.; Philip, S.G.; Hendriksz, C.; Morton, J.E.; Kingston, H.M.; Rosser, E.M.; Wassmer, E.; Gissen, P.; Maher, E.R. Phenotypic spectrum of neurodegeneration associated with mutations in the PLA2G6 gene (PLAN). Neurology, 2008, 70(18), 1623-1629.
34. Paisan-Ruiz, C.; Bhatia, K.P.; Li, A.; Hernandez, D.; Davis, M.; Wood, N.W.; Hardy, J.; Houlden, H.; Singleton, A.; Schneider, S.A. Characterization of PLA2G6 as a locus for dystoniaparkinsonism. Ann. Neurol., 2009, 65(1), 19-23.
35. Shojaee, S.; Sina, F.; Banihosseini, S.S.; Kazemi, M.H.; Kalhor, R.; Shahidi, G.A.; Fakhrai-Rad, H.; Ronaghi, M.; Elahi, E. Genomewide linkage analysis of a Parkinsonian-pyramidal syndrome pedigree by 500 K SNP arrays. Am. J. Hum. Genet., 2008, 82(6), 1375-1384.
36. Di Fonzo, A.; Dekker, M.C.; Montagna, P.; Baruzzi, A.; Yonova, E.H.; Correia Guedes, L.; Szczerbinska, A.; Zhao, T.; Dubbel-Hulsman, L.O.; Wouters, C.H.; de Graaff, E.; Oyen, W.J.; Simons, E.J.; Breedveld, G.J.; Oostra, B.A.; Horstink, M.W.; Bonifati, V. FBXO7 mutations cause autosomal recessive, early-onset parkinsonian-pyramidal syndrome. Neurology, 2009, 72(3), 240-245.
37. Paisan-Ruiz, C.; Guevara, R.; Federoff, M.; Hanagasi, H.; Sina, F.; Elahi, E.; Schneider, S.A.; Schwingenschuh, P.; Bajaj, N.; Emre, M.; Singleton, A.B.; Hardy, J.; Bhatia, K.P.; Brandner, S.; Lees, A.J.; Houlden, H. Early-onset L-dopa-responsive parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and spatacsin mutations. Mov. Disord., 2010, 25(12), 1791-1800.
38. Vilarino-Guell, C.; Wider, C.; Ross, O.A.; Dachsel, J.C.; Kachergus, J.M.; Lincoln, S.J.; Soto-Ortolaza, A.I.; Cobb, S.A.; Wilhoite, G.J.; Bacon, J.A.; Behrouz, B.; Melrose, H.L.; Hentati, E.; Puschmann, A.; Evans, D.M.; Conibear, E.; Wasserman, W.W.; Aasly, J.O.; Burkhard, P.R.; Djaldetti, R.; Ghika, J.; Hentati, F.; Krygowska-Wajs, A.; Lynch, T.; Melamed, E.; Rajput, A.; Rajput, A.H.; Solida, A.; Wu, R.M.; Uitti, R.J.; Wszolek, Z.K.; Vingerhoets, F.; Farrer, M.J. VPS35 mutations in Parkinson disease. Am. J. Hum. Genet., 89(1), 162-167.
39. Zimprich, A.; Benet-Pages, A.; Struhal, W.; Graf, E.; Eck, S.H.; Offman, M.N.; Haubenberger, D.; Spielberger, S.; Schulte, E.C.; Lichtner, P.; Rossle, S.C.; Klopp, N.; Wolf, E.; Seppi, K.; Pirker, W.; Presslauer, S.; Mollenhauer, B.; Katzenschlager, R.; Foki, T.; Hotzy, C.; Reinthaler, E.; Harutyunyan, A.; Kralovics, R.; Peters, A.; Zimprich, F.; Brucke, T.; Poewe, W.; Auff, E.; Trenkwalder, C.; Rost, B.; Ransmayr, G.; Winkelmann, J.; Meitinger, T.; Strom, T.M. A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease. Am. J. Hum. Genet., 2011, 89(1), 168-175.
40. Kruger, R.; Vieira-Saecker, A.M.; Kuhn, W.; Berg, D.; Muller, T.; Kuhnl, N.; Fuchs, G.A.; Storch, A.; Hungs, M.; Woitalla, D.; Przuntek, H.; Epplen, J.T.; Schols, L.; Riess, O. Increased susceptibility to sporadic Parkinson's disease by a certain combined alphasynuclein/ apolipoprotein E genotype. Ann. Neurol., 1999, 45(5), 611-617.
41. Maraganore, D.M.; de Andrade, M.; Elbaz, A.; Farrer, M.J.; Ioannidis, J.P.; Kruger, R.; Rocca, W.A.; Schneider, N.K.; Lesnick, T.G.; Lincoln, S.J.; Hulihan, M.M.; Aasly, J.O.; Ashizawa, T.; Chartier-Harlin, M.C.; Checkoway, H.; Ferrarese, C.; Hadjigeorgiou, G.; Hattori, N.; Kawakami, H.; Lambert, J.C.; Lynch, T.; Mellick, G.D.; Papapetropoulos, S.; Parsian, A.; Quattrone, A.; Riess, O.; Tan, E.K.; Van Broeckhoven, C. Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease. JAMA, 2006, 296(6), 661-670.
42. Chiba-Falek, O.; Nussbaum, R.L. Effect of allelic variation at the NACP-Rep1 repeat upstream of the alpha-synuclein gene (SNCA) on transcription in a cell culture luciferase reporter system. Hum. Mol. Genet., 2001, 10(26), 3101-3109.
43. Do, C.B.; Tung, J.Y.; Dorfman, E.; Kiefer, A.K.; Drabant, E.M.; Francke, U.; Mountain, J.L.; Goldman, S.M.; Tanner, C.M.; Langston, J.W.; Wojcicki, A.; Eriksson, N. Web-based genome-wide association study identifies two novel loci and a substantial genetic component for Parkinson's disease. PLoS Genet., 2011, 7(6), e1002141.
44. Lill, C.M.; Roehr, J.T.; McQueen, M.B.; Kavvoura, F.K.; Bagade, S.; Schjeide, B.M.; Schjeide, L.M.; Meissner, E.; Zauft, U.; Allen, N.C.; Liu, T.; Schilling, M.; Anderson, K.J.; Beecham, G.; Berg, D.; Biernacka, J.M.; Brice, A.; DeStefano, A.L.; Do, C.B.; Eriksson, N.; Factor, S.A.; Farrer, M.J.; Foroud, T.; Gasser, T.; Hamza, T.; Hardy, J.A.; Heutink, P.; Hill-Burns, E.M.; Klein, C.; Latourelle, J.C.; Maraganore, D.M.; Martin, E.R.; Martinez, M.; Myers, R.H.; Nalls, M.A.; Pankratz, N.; Payami, H.; Satake, W.; Scott, W.K.; Sharma, M.; Singleton, A.B.; Stefansson, K.; Toda, T.; Tung, J.Y.; Vance, J.; Wood, N.W.; Zabetian, C.P.; Young, P.; Tanzi, R.E.; Khoury, M.J.; Zipp, F.; Lehrach, H.; Ioannidis, J.P.; Bertram, L. Comprehensive research synopsis and systematic metaanalyses in Parkinson's disease genetics: The PDGene database. PLoS Genet., 2012, 8(3), e1002548.
45. Nalls, M.A.; Plagnol, V.; Hernandez, D.G.; Sharma, M.; Sheerin, U.M.; Saad, M.; Simon-Sanchez, J.; Schulte, C.; Lesage, S.; Sveinbjornsdottir, S.; Stefansson, K.; Martinez, M.; Hardy, J.; Heutink, P.; Brice, A.; Gasser, T.; Singleton, A.B.; Wood, N.W. Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies. Lancet, 2011, 377(9766), 641-649.
46. Mata, I.F.; Shi, M.; Agarwal, P.; Chung, K.A.; Edwards, K.L.; Factor, S.A.; Galasko, D.R.; Ginghina, C.; Griffith, A.; Higgins, D.S.; Kay, D.M.; Kim, H.; Leverenz, J.B.; Quinn, J.F.; Roberts, J.W.; Samii, A.; Snapinn, K.W.; Tsuang, D.W.; Yearout, D.; Zhang, J.; Payami, H.; Zabetian, C.P. SNCA variant associated with Parkinson disease and plasma alpha-synuclein level. Arch. Neurol., 2010, 67(11), 1350-1356.
47. Myhre, R.; Toft, M.; Kachergus, J.; Hulihan, M.M.; Aasly, J.O.; Klungland, H.; Farrer, M.J. Multiple alpha-synuclein gene polymorphisms are associated with Parkinson's disease in a Norwegian population. Acta Neurol. Scand., 2008, 118(5), 320-327.
48. Aharon-Peretz, J.; Rosenbaum, H.; Gershoni-Baruch, R. Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews. N. Engl. J. Med., 2004, 351(19), 1972-1977.
49. Bras, J.; Paisan-Ruiz, C.; Guerreiro, R.; Ribeiro, M.H.; Morgadinho, A.; Januario, C.; Sidransky, E.; Oliveira, C.; Singleton, A. Complete screening for glucocerebrosidase mutations in Parkinson disease patients from Portugal. Neurobiol. Aging, 2009, 30(9), 1515-1517.
50. Kalinderi, K.; Bostantjopoulou, S.; Paisan-Ruiz, C.; Katsarou, Z.; Hardy, J.; Fidani, L. Complete screening for glucocerebrosidase mutations in Parkinson disease patients from Greece. Neurosci. Lett., 2009, 452(2), 87-89.
51. Mao, X.Y.; Burgunder, J.M.; Zhang, Z.J.; An, X.K.; Zhang, J.H.; Yang, Y.; Li, T.; Wang, Y.C.; Chang, X.L.; Peng, R. Association between GBA L444P mutation and sporadic Parkinson's disease from Mainland China. Neurosci. Lett., 2010, 469(2), 256-259.
52. Neumann, J.; Bras, J.; Deas, E.; O'Sullivan, S.S.; Parkkinen, L.; Lachmann, R.H.; Li, A.; Holton, J.; Guerreiro, R.; Paudel, R.; Segarane, B.; Singleton, A.; Lees, A.; Hardy, J.; Houlden, H.; Revesz, T.; Wood, N.W. Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease. Brain, 2009, 132(Pt 7), 1783-1794.
53. Spitz, M.; Rozenberg, R.; Pereira Lda, V.; Reis Barbosa, E. Association between Parkinson's disease and glucocerebrosidase mutations in Brazil. Parkinsonism Relat. Disord., 2008, 14(1), 58-62.
54. Toft, M.; Pielsticker, L.; Ross, O.A.; Aasly, J.O.; Farrer, M.J. Glucocerebrosidase gene mutations and Parkinson disease in the Norwegian population. Neurology, 2006, 66(3), 415-417.
55. Sidransky, E.; Nalls, M.A.; Aasly, J.O.; Aharon-Peretz, J.; Annesi, G.; Barbosa, E.R.; Bar-Shira, A.; Berg, D.; Bras, J.; Brice, A.; Chen, C.M.; Clark, L.N.; Condroyer, C.; De Marco, E.V.; Durr, A.; Eblan, M.J.; Fahn, S.; Farrer, M.J.; Fung, H.C.; Gan-Or, Z.; Gasser, T.; Gershoni-Baruch, R.; Giladi, N.; Griffith, A.; Gurevich, T.; Januario, C.; Kropp, P.; Lang, A.E.; Lee-Chen, G.J.; Lesage, S.; Marder, K.; Mata, I.F.; Mirelman, A.; Mitsui, J.; Mizuta, I.; Nicoletti, G.; Oliveira, C.; Ottman, R.; Orr-Urtreger, A.; Pereira, L.V.; Quattrone, A.; Rogaeva, E.; Rolfs, A.; Rosenbaum, H.; Rozenberg, R.; Samii, A.; Samaddar, T.; Schulte, C.; Sharma, M.; Singleton, A.; Spitz, M.; Tan, E.K.; Tayebi, N.; Toda, T.; Troiano, A.R.; Tsuji, S.; Wittstock, M.; Wolfsberg, T.G.; Wu, Y.R.; Zabetian, C.P.; Zhao, Y.; Ziegler, S.G. Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N. Engl. J. Med., 2009, 361(17), 1651-1661.
56. Alcalay, R.N.; Caccappolo, E.; Mejia-Santana, H.; Tang, M.; Rosado, L.; Orbe Reilly, M.; Ruiz, D.; Ross, B.; Verbitsky, M.; Kisselev, S.; Louis, E.; Comella, C.; Colcher, A.; Jennings, D.; Nance, M.; Bressman, S.; Scott, W.K.; Tanner, C.; Mickel, S.; Andrews, H.; Waters, C.; Fahn, S.; Cote, L.; Frucht, S.; Ford, B.; Rezak, M.; Novak, K.; Friedman, J.H.; Pfeiffer, R.; Marsh, L.; Hiner, B.; Siderowf, A.; Payami, H.; Molho, E.; Factor, S.; Ottman, R.; Clark, L.N.; Marder, K. Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study. Neurology, 2012, 78(18), 1434-1440.
57. Winder-Rhodes, S.E.; Evans, J.R.; Ban, M.; Mason, S.L.; Williams-Gray, C.H.; Foltynie, T.; Duran, R.; Mencacci, N.E.; Sawcer, S.J.; Barker, R.A. Glucocerebrosidase mutations influence the natural history of Parkinson's disease in a community-based incident cohort. Brain, 2013, 136(Pt 2), 392-399.
58. Seto-Salvia, N.; Pagonabarraga, J.; Houlden, H.; Pascual-Sedano, B.; Dols-Icardo, O.; Tucci, A.; Paisan-Ruiz, C.; Campolongo, A.; Anton-Aguirre, S.; Martin, I.; Munoz, L.; Bufill, E.; Vilageliu, L.; Grinberg, D.; Cozar, M.; Blesa, R.; Lleo, A.; Hardy, J.; Kulisevsky, J.; Clarimon, J. Glucocerebrosidase mutations confer a greater risk of dementia during Parkinson's disease course. Mov. Disord., 2012, 27(3), 393-399.
59. Farrer, M.; Skipper, L.; Berg, M.; Bisceglio, G.; Hanson, M.; Hardy, J.; Adam, A.; Gwinn-Hardy, K.; Aasly, J. The tau H1 haplotype is associated with Parkinson's disease in the Norwegian population. Neurosci. Lett., 2002, 322(2), 83-86.
60. Satake, W.; Nakabayashi, Y.; Mizuta, I.; Hirota, Y.; Ito, C.; Kubo, M.; Kawaguchi, T.; Tsunoda, T.; Watanabe, M.; Takeda, A.; Tomiyama, H.; Nakashima, K.; Hasegawa, K.; Obata, F.; Yoshikawa, T.; Kawakami, H.; Sakoda, S.; Yamamoto, M.; Hattori, N.; Murata, M.; Nakamura, Y.; Toda, T. Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nat. Genet., 2009, 41(12), 1303-1307.
61. Donnelly, M.P.; Paschou, P.; Grigorenko, E.; Gurwitz, D.; Mehdi, S.Q.; Kajuna, S.L.; Barta, C.; Kungulilo, S.; Karoma, N.J.; Lu, R.B.; Zhukova, O.V.; Kim, J.J.; Comas, D.; Siniscalco, M.; New, M.; Li, P.; Li, H.; Manolopoulos, V.G.; Speed, W.C.; Rajeevan, H.; Pakstis, A.J.; Kidd, J.R.; Kidd, K.K. The distribution and most recent common ancestor of the 17q21 inversion in humans. Am. J. Hum. Genet., 2010, 86(2), 161-171.
62. Evans, W.; Fung, H.C.; Steele, J.; Eerola, J.; Tienari, P.; Pittman, A.; Silva, R.; Myers, A.; Vrieze, F.W.; Singleton, A.; Hardy, J. The tau H2 haplotype is almost exclusively Caucasian in origin. Neurosci. Lett., 2004, 369(3), 183-185.
63. Goris, A.; Williams-Gray, C.H.; Clark, G.R.; Foltynie, T.; Lewis, S.J.; Brown, J.; Ban, M.; Spillantini, M.G.; Compston, A.; Burn, D.J.; Chinnery, P.F.; Barker, R.A.; Sawcer, S.J. Tau and alphasynuclein in susceptibility to, and dementia in, Parkinson's disease. Ann. Neurol., 2007, 62(2), 145-153.
64. Williams-Gray, C.H.; Evans, J.R.; Goris, A.; Foltynie, T.; Ban, M.; Robbins, T.W.; Brayne, C.; Kolachana, B.S.; Weinberger, D.R.; Sawcer, S.J.; Barker, R.A. The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort. Brain, 2009, 132(Pt 11), 2958-2969.
65. Seto-Salvia, N.; Clarimon, J.; Pagonabarraga, J.; Pascual-Sedano, B.; Campolongo, A.; Combarros, O.; Mateo, J.I.; Regana, D.; Martinez-Corral, M.; Marquie, M.; Alcolea, D.; Suarez-Calvet, M.; Molina-Porcel, L.; Dols, O.; Gomez-Isla, T.; Blesa, R.; Lleo, A.; Kulisevsky, J. Dementia risk in Parkinson disease: disentangling the role of MAPT haplotypes. Arch. Neurol., 2011, 68(3), 359-364.
66. Williams-Gray, C.H.; Mason, S.L.; Evans, J.R.; Foltynie, T.; Brayne, C.; Robbins, T.W.; Barker, R.A. The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident populationbased cohort. J. Neurol. Neurosurg. Psychiatry, 2013, 84(11), 1258-64.
67. Morley, J.F.; Xie, S.X.; Hurtig, H.I.; Stern, M.B.; Colcher, A.; Horn, S.; Dahodwala, N.; Duda, J.E.; Weintraub, D.; Chen-Plotkin, A.S.; Van Deerlin, V.; Falcone, D.; Siderowf, A. Genetic influences on cognitive decline in Parkinson's disease. Mov. Disord., 2012, 27(4), 512-518.
68. Maraganore, D.M.; de Andrade, M.; Lesnick, T.G.; Strain, K.J.; Farrer, M.J.; Rocca, W.A.; Pant, P.V.; Frazer, K.A.; Cox, D.R.; Ballinger, D.G. High-resolution whole-genome association study of Parkinson disease. Am. J. Hum. Genet., 2005, 77(5), 685-693.
69. Fung, H.C.; Scholz, S.; Matarin, M.; Simon-Sanchez, J.; Hernandez, D.; Britton, A.; Gibbs, J.R.; Langefeld, C.; Stiegert, M.L.; Schymick, J.; Okun, M.S.; Mandel, R.J.; Fernandez, H.H.; Foote, K.D.; Rodriguez, R.L.; Peckham, E.; De Vrieze, F.W.; Gwinn-Hardy, K.; Hardy, J.A.; Singleton, A. Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of data. Lancet Neurol., 2006, 5(11), 911-916.
70. Kruger, R.; Sharma, M.; Riess, O.; Gasser, T.; Van Broeckhoven, C.; Theuns, J.; Aasly, J.; Annesi, G.; Bentivoglio, A.R.; Brice, A.; Djarmati, A.; Elbaz, A.; Farrer, M.; Ferrarese, C.; Gibson, J.M.; Hadjigeorgiou, G.M.; Hattori, N.; Ioannidis, J.P.; Jasinska-Myga, B.; Klein, C.; Lambert, J.C.; Lesage, S.; Lin, J.J.; Lynch, T.; Mellick, G.D.; de Nigris, F.; Opala, G.; Prigione, A.; Quattrone, A.; Ross, O.A.; Satake, W.; Silburn, P.A.; Tan, E.K.; Toda, T.; Tomiyama, H.; Wirdefeldt, K.; Wszolek, Z.; Xiromerisiou, G.; Maraganore, D.M. A large-scale genetic association study to evaluate the contribution of Omi/HtrA2 (PARK13) to Parkinson's disease. Neurobiol. Aging, 2011, 32(3), 548 e549-518.
71. Simon-Sanchez, J.; Schulte, C.; Bras, J.M.; Sharma, M.; Gibbs, J.R.; Berg, D.; Paisan-Ruiz, C.; Lichtner, P.; Scholz, S.W.; Hernandez, D.G.; Kruger, R.; Federoff, M.; Klein, C.; Goate, A.; Perlmutter, J.; Bonin, M.; Nalls, M.A.; Illig, T.; Gieger, C.; Houlden, H.; Steffens, M.; Okun, M.S.; Racette, B.A.; Cookson, M.R.; Foote, K.D.; Fernandez, H.H.; Traynor, B.J.; Schreiber, S.; Arepalli, S.; Zonozi, R.; Gwinn, K.; van der Brug, M.; Lopez, G.; Chanock, S.J.; Schatzkin, A.; Park, Y.; Hollenbeck, A.; Gao, J.; Huang, X.; Wood, N.W.; Lorenz, D.; Deuschl, G.; Chen, H.; Riess, O.; Hardy, J.A.; Singleton, A.B.; Gasser, T. Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat. Genet., 2009, 41(12), 1308-1312.
72. Pankratz, N.; Wilk, J.B.; Latourelle, J.C.; DeStefano, A.L.; Halter, C.; Pugh, E.W.; Doheny, K.F.; Gusella, J.F.; Nichols, W.C.; Foroud, T.; Myers, R.H. Genomewide association study for susceptibility genes contributing to familial Parkinson disease. Hum. Genet., 2009, 124(6), 593-605.
73. Edwards, T.L.; Scott, W.K.; Almonte, C.; Burt, A.; Powell, E.H.; Beecham, G.W.; Wang, L.; Zuchner, S.; Konidari, I.; Wang, G.; Singer, C.; Nahab, F.; Scott, B.; Stajich, J.M.; Pericak-Vance, M.; Haines, J.; Vance, J.M.; Martin, E.R. Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease. Ann. Hum. Genet., 2010, 74(2), 97-109.
74. Hamza, T.H.; Zabetian, C.P.; Tenesa, A.; Laederach, A.; Montimurro, J.; Yearout, D.; Kay, D.M.; Doheny, K.F.; Paschall, J.; Pugh, E.; Kusel, V.I.; Collura, R.; Roberts, J.; Griffith, A.; Samii, A.; Scott, W.K.; Nutt, J.; Factor, S.A.; Payami, H. Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease. Nat Genet, 2010, 42(9), 781-785.
75. Simon-Sanchez, J.; van Hilten, J.J.; van de Warrenburg, B.; Post, B.; Berendse, H.W.; Arepalli, S.; Hernandez, D.G.; de Bie, R.M.; Velseboer, D.; Scheffer, H.; Bloem, B.; van Dijk, K.D.; Rivadeneira, F.; Hofman, A.; Uitterlinden, A.G.; Rizzu, P.; Bochdanovits, Z.; Singleton, A.B.; Heutink, P. Genome-wide association study confirms extant PD risk loci among the Dutch. Eur. J. Hum. Genet., 2011, 19(6), 655-661.
76. Spencer, C.C.; Plagnol, V.; Strange, A.; Gardner, M.; Paisan-Ruiz, C.; Band, G.; Barker, R.A.; Bellenguez, C.; Bhatia, K.; Blackburn, H.; Blackwell, J.M.; Bramon, E.; Brown, M.A.; Burn, D.; Casas, J.P.; Chinnery, P.F.; Clarke, C.E.; Corvin, A.; Craddock, N.; Deloukas, P.; Edkins, S.; Evans, J.; Freeman, C.; Gray, E.; Hardy, J.; Hudson, G.; Hunt, S.; Jankowski, J.; Langford, C.; Lees, A.J.; Markus, H.S.; Mathew, C.G.; McCarthy, M.I.; Morrison, K.E.; Palmer, C.N.; Pearson, J.P.; Peltonen, L.; Pirinen, M.; Plomin, R.; Potter, S.; Rautanen, A.; Sawcer, S.J.; Su, Z.; Trembath, R.C.; Viswanathan, A.C.; Williams, N.W.; Morris, H.R.; Donnelly, P.; Wood, N.W. Dissection of the genetics of Parkinson's disease identifies an additional association 5' of SNCA and multiple associated haplotypes at 17q21. Hum. Mol. Genet., 2011, 20(2), 345-353.
77. A two-stage meta-analysis identifies several new loci for Parkinson's disease. PLoS Genet., 2011, 7(6), e1002142.
78. Alcalay, R.N.; Caccappolo, E.; Mejia-Santana, H.; Tang, M.X.; Rosado, L.; Ross, B.M.; Verbitsky, M.; Kisselev, S.; Louis, E.D.; Comella, C.; Colcher, A.; Jennings, D.; Nance, M.A.; Bressman, S.B.; Scott, W.K.; Tanner, C.; Mickel, S.; Andrews, H.; Waters, C.; Fahn, S.; Cote, L.; Frucht, S.; Ford, B.; Rezak, M.; Novak, K.; Friedman, J.H.; Pfeiffer, R.; Marsh, L.; Hiner, B.; Siderowf, A.; Ottman, R.; Marder, K.; Clark, L.N. Frequency of known mutations in early-onset Parkinson disease: implication for genetic counseling: the consortium on risk for early onset Parkinson disease study. Arch. Neurol., 2010, 67(9), 1116-1122.
79. Mata, I.F.; Samii, A.; Schneer, S.H.; Roberts, J.W.; Griffith, A.; Leis, B.C.; Schellenberg, G.D.; Sidransky, E.; Bird, T.D.; Leverenz, J.B.; Tsuang, D.; Zabetian, C.P. Glucocerebrosidase gene mutations: a risk factor for Lewy body disorders. Arch. Neurol., 2008, 65(3), 379-382.